Author:
Broach John,Brown Olga,McEachern Caitlin,Forget Janell,Lancette Peter,Soucie Norman,Inzerillo Julie,Klugman Robert,Tosi Stephen,Haddad Abraham,Manor Pamela,Bylund Richard,Dellostritto Gio,Grecchi Max,Camelo Connie,Shirshac Jeanne,Eshghi Katharine,Vega Nardy,Hampson Stacy,Follwell Kassandra,Gonzalez Rafael,Hicks Theresa,McCandless Victoria,VanStratten Timothy,Botros Mina,Jalbert Tracy,Merwin Catherine,Schellhammer Wendy,Pelto Ian,Rodriguez Maggie,LaPriore Cheryl,Lowell Monica,Radigan Elizabeth,Gull Lorie,Gruszecki Alana,Benoit Sarah,Dickson Eric,Muller Michelle
Abstract
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers to accessing healthcare. In the setting of these difficulties, a program was created specifically to address inequity in vaccine administration with a focus on communities of color and linguistic diversity as well as those who had technological barriers to online sign-up processes common at mass vaccination sites. This effort, the Mobile Vaccine Equity Enhancement Program (MVeeP), delivered over 12,000 vaccines in 24 months through a reproducible set of practices that can inform equity-driven vaccine efforts in future pandemics.
Subject
Public Health, Environmental and Occupational Health